Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more


The latest news for pharma industry insiders.

Addressing Uncertainties Associated Medication Approved Through Accelerated Approval Pathway

In this Pharmaceutical Executive video interview, Optum Rx clinical pharmacist, Arash Sadeghi, discusses how healthcare providers and patients navigate the potential benefits and uncertainties associated with a medication approved through the accelerated approval pathway.

Understanding DSCSA: Insights for All Dispensers

As the full act will be enforced in November 2024, all medication dispensers must ensure they’re fully prepared.

The Department of Homeland Security Is Embracing AI

The agency will be the first in the federal government to roll out a comprehensive plan to integrate the technology into a variety of uses, from fighting crime to helping disaster survivors.

Maintaining Wellness Among Healthcare Workers

Addressing the issue of employee wellness in healthcare, the American Association for Physician Leadership (AAPL) has published a new book, Working Happy! How to Survive Burnout and Find Your Work/Life Synergy in the Healthcare Industry.

PAN Foundation on LinkedIn:

We were honored to debut the 2024 State of Patient Access report at Informa's Patient Assistance & Access Programs (PAP) conference last week. Learn more about the report, and some key takeaways about how the medical system is not getting high grades from patients, in this Pharmaceutical Commerce Magazine recap by Nicholas Saraceno.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.